Schizophrenia Clinical Trials in Houston

Showing 1-20 of 67 trials

Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia

NCT05859698

This study will evaluate the effectiveness of valbenazine on patient- and clinician-reported outcomes assessing health-related quality of life, functioning, and treatment effect in participants with tardive dyskinesia (TD) who are receiving valbenazine for up to 24 weeks.

SchizophreniaSchizoaffective DisorderBipolar Disorder+2 more

Neurocrine Biosciences59 participantsStarted May 2023

Bryant, Arkansas, United States • Anaheim, California, United States • Orange, California, United States +15 more locations

RECRUITINGPHASE3< 1 mile

Randomized Withdrawal Study in Patients With Schizophrenia

NCT06961968

The purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exacerbation of symptoms in patients with schizophrenia.

Schizophrenia

Vanda Pharmaceuticals400 participantsStarted May 2025

Rogers, Arkansas, United States • Costa Mesa, California, United States • Lemon Grove, California, United States +19 more locations

Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia

Randomized Withdrawal Study in Patients With Schizophrenia

Schizophrenia Trials in Other Cities

Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia

A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia

A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia

A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms

This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia

Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia

A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder

ERG Components in Schizophrenia and Bipolar Disorder Type I

A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia

Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and Healthy Participants (MK-8189-011)

Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder

A Study To Evaluate The Effect Of A Supratherapeutic Dose Of MK-8189 On The QTc Interval In Participants With Schizophrenia (MK-8189-019)

Other Conditions in Houston